This Practice Note provides practical guidance on sanitary and phytosanitary (SPS) measures under the UK and Japan Comprehensive Economic Partnership Agreement (UK-Japan CEPA). Introduction The UK-Japan CEPA covers trade in goods between Great Britain and Northern Ireland and Japan. It also covers topics related to trade in goods such as rules of origin, trade remedies, sanitary and phytosanitary (SPS) measures and technical barriers to trade (TBT). This Practice Note only deals with SPS measures under the UK-Japan CEPA. SPS measures are regulated under Chapter 6 of the UK-Japan CEPA. The objectives of this Chapter are to: • protect human, animal or plant life or health through development, adoption and enforcement of SPS measures while minimising their negative effects on trade between the UK and Japan • promote cooperation between the UK and Japan on the Implementation of the World Trade Organization’s (WTO) SPS Agreement, and • provide means for improving communication and cooperation between the UK and Japan, a framework for addressing matters related to the implementation of SPS measures and means for

This Practice Note provides practical guidance on the sanitary and phytosanitary (SPS) measures under the Australia and United Kingdom Free Trade Agreement (Aus-UK FTA). Introduction The Aus-UK FTA covers trade in goods and services as well as a host of topics associated with trade in goods and services. For example, in the context of trade in goods, the Aus-UK FTA addresses: • rules of origin. For guidance on rules of origin under the Aus-UK FTA, see Practice Note: Rules of origin of the Aus-UK FTA. For guidance on claiming origin under the Aus-UK FTA, see Practice Note: How to claim preference under the Aus-UK FTA • customs procedure and trade facilitation • technical barriers to trade, and • trade remedies Chapter 6 of the Aus-UK FTA deals with SPS measures. Chapter 6 seeks to: • protect human, animal and plant life and health in the territory of the parties while facilitating trade between them • ensure that the parties' SPS measures do not create unjustified barriers to trade • reinforce and build upon

This Practice Note provides practical guidance on sanitary and phytosanitary (SPS) measures under the Comprehensive and Progressive Trans-Pacific Partnership Agreement (CPTPP). Introduction THE CPTPP is a free trade agreement made up for 11 countries, being Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. It follows on from the original Trans-Pacific Partnership Agreement (TTP) to which the United States was also a negotiating partner. In fact, the CPTPP incorporates all of the provisions of the TPP save for the provisions relating to accession, entry into force, withdrawal and what constitutes the authentic texts of the TPP. Several other countries have applied to join the CPTPP which includes China, Costa Rica, Ecuador, Taiwan and Uruguay. The UK also applied to join the CPTPP on 1 February 2021. On 31 March 2023, the UK government announced that it had substantially concluded negotiations on acceding to the CPTPP. On 15 July 2023, the UK acceded to the CPTPP at a meeting of CPTPP trade ministers. The trade deal that the UK struck

This Practice Note provides practical guidance on Chapter 3 of the UK-EU Trade and Cooperation Agreement which regulates the usage of sanitary and phytosanitary (SPS) measures in trade between the UK and the EU. It provides guidance on the scope of SPS measures in the Trade and Cooperation Agreement (TCA), the rights and obligations of the UK and the EU, the general principles of SPS measures in the TCA, certification, import conditions, notification requirements, reliance on emergency SPS measures and the cooperation between the parties. Introduction As a free trade agreement, the TCA not only regulates tariffs on goods traded between these two customs territories, but it also addresses other aspects that are required to trade in goods or that may be regarded as non-tariff barriers to trade. This includes: • rules of origin • technical barriers to trade, and • SPS measures Chapter 3 of the TCA deals with SPS. The Chapter seeks to: • protect human, animal and plant life or health while facilitating trade and not

This Practice Note provides practical guidance on the sanitary and phytosanitary (SPS) measures under the UK and India Comprehensive Economic and Trade Agreements (UK-India CETA). Introduction The UK-India CETA covers trade in goods and services as well as a host of associated with trade in goods and services. For example, in the context of trade in goods, the UK-India CETA addresses: • rules of origin • customs and trade facilitation • technical barriers to trade, and • trade remedies Chapter 6 of the UK-India CETA deals with SPS measures. Chapter 6 seeks to: • protect human, animal and plant life and health in the territory of the parties while facilitating trade between them • ensure that the parties' SPS measures do not create unjustified barriers to trade • reinforce and build upon the implementation of the World Trade Organization’s (WTO) SPS Agreement. For guidance on WTO’s SPS Agreement, see Practice Note: An introduction to the Agreement on the Application of Sanitary and Phytosanitary Measures • promote greater transparency and understanding on the

CASE HUB ARCHIVED—this archived case hub reflects the position at the date of the Commission’s decision to accept commitments on 14 October 2026; it is no longer maintained. See further, timeline Case facts Outline European Commission (Commission) Article 102 TFEU investigation into whether Sanofi abused its dominant position by conducting a misleading communication campaign disparaging a competing enhanced flu vaccine, Fluad, in Germany and France (Case AT.40998). Latest development On 14 October 2026, the Commission accepted commitments offered by Sanofi addressing its preliminary concerns regarding the possible disparagement of Fluad, and closed its investigation. Parties • Sanofi S.A. (Sanofi): Sanofi, headquartered in France, is a multinational company active in the research, development and manufacture of prescription medicines, vaccines and healthcare solutions. Its enhanced flu vaccine, marketed in the EU as Efluelda, competes with Fluad, marketed by CSL Seqirus. Background The Commission carried out unannounced inspections at Sanofi’s premises in September 2025.On 26 June 2026, the Commission opened formal proceedings and adopted a Preliminary Assessment setting out its competition concerns.On

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 9 July 2019; it is no longer maintained. See further, timeline commentary andrelated cases. Case facts Outline European Commission Article 101 investigation into vertical restrictions banning traders from selling licensed merchandise to other countries within the EEA. This restriction concerned products featuring Hello Kitty or other characters owned by Sanrio. Latest development On 9 July 2019, the Commission issued its infringement decision against Sanrio, imposing a fine of €6,220,000 (following an ‘informal settlement’), for imposing vertical restrictions on the cross-border sale of licensed products featuring Hello Kitty or other characters in breach of Article 101 TFEU. Parties Sanrio Company, Ltd (Sanrio) is a Japanese company that designs, licenses, produces and sells products featuring Hello Kitty, an anthropomorphic cat girl also known by her full name Kitty White, and other popular characters such as My Melody, Little Twin

Law360, London: Santander UK Plc defeated a fraud victim's claim over the bank allowing more than £415,000 to be transferred away to scammers, after a London court ruled on 25 March 2025 that the allegation had no realistic prospect of succeeding.

Law360: The Employment Appeal Tribunal (EAT) has rejected an appeal by a former financial crime policy manager at Santander to revive her whistleblowing and discrimination claims against the bank, ruling a fair trial was not possible because she failed to exchange witness statements.

Law360: Santander Cards UK Ltd and Skipton Building Society have fought off attempts by customers to revive claims alleging the lenders' offers to compensate them for misselling payment protection insurance were invalid.

Financial Services analysis: Sara Cody, Counsel in Linklaters’ Financial Services Regulatory team, considers the shifting landscape of the Consumer Duty as the final implementation deadline passes. She provides key takeaways from Financial Conduct Authority (FCA) feedback this year, particularly in relation to firms’ first board reporting process, data and monitoring capabilities, closed products and vulnerable customers, highlights what to expect on the horizon and sets out practical steps to assist firms’ compliance.

The Financial Conduct Authority (FCA) has published a speech by its executive director for markets and executive director for international, Sarah Pritchard, on the regulator’s ‘targeted and outcomes-based approach’ to tackling financial crime, which includes working with other regulatory and law enforcement partners like the National Crime Agency (NCA). Pritchard said the aim of this approach is to highlight the importance of having the FCA ‘at the table alongside industry and law enforcement to answer the question: what will the regulator think of this?’. She also notes that in the last year, the FCA has ‘taken a leading role in influencing Big Tech companies to stop scams and illegal ads from appearing on their platforms’.